Are pancreatic neuroendocrine tumors benign or malignant?
Whether pancreatic neuroendocrine tumors (PNETs) are benign or malignant usually depends on the nature and behavior of the tumor. A detailed analysis is as follows:
1. Benign
If there is no invasion into surrounding tissues or distant metastasis, the tumor is generally considered benign. In such cases, the functions of surrounding tissues and organs are not significantly impaired, and the prognosis is usually favorable.
2. Malignant
If the tumor invades surrounding tissues and has metastasized, it is generally considered malignant. Malignant tumors typically grow rapidly, may compress and damage adjacent tissues and organs, and can spread to other parts of the body via the bloodstream or lymphatic system, leading to distant metastases. Malignant PNETs usually require aggressive treatment and have a poorer prognosis.
Patients experiencing significant discomfort should seek timely medical attention to avoid delays in diagnosis and treatment. It is also important to maintain healthy lifestyle habits and avoid spicy or irritating foods, which may impair recovery.